Svanholm H, Hørder M
Department of Pathology, Odense University Hospital, Denmark.
Scand J Urol Nephrol Suppl. 1988;107:65-70.
Immunohistochemical techniques using antibodies to prostate specific antigen (PSA) and prostate specific acid phosphatase (PAP) have greatly increased the feasibility of reliable diagnosis of primary or metastatic prostatic carcinoma. A review of the literature showed the diagnostic specificity of antibodies to PSA or PAP to be 100% and 87-100%, respectively. The corresponding figures for diagnostic sensitivity were 94-100% and 90-100%.
使用针对前列腺特异性抗原(PSA)和前列腺特异性酸性磷酸酶(PAP)的抗体的免疫组织化学技术,极大地提高了可靠诊断原发性或转移性前列腺癌的可行性。文献综述显示,针对PSA或PAP的抗体的诊断特异性分别为100%和87 - 100%。相应的诊断敏感性数字分别为94 - 100%和90 - 100%。